Lessons in AIDS vaccine development learned from studies of equine infectious, anemia virus infection and immunity

Viruses

Volumn 5, Issue 12, 2013, Pages 2963-2976

  Craigo, Jodi K ^a   Montelaro, Ronald C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

EIAV; Envelope diversity; Immune maturation; Lentivirus; Pathogenesis; Vaccine development

Indexed keywords

ENVELOPE PROTEIN; HUMAN IMMUNODEFICIENCY VIRUS VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGENIC VARIATION; EQUINE INFECTIOUS ANEMIA; EQUINE INFECTIOUS ANEMIA VIRUS; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; LENTIVIRINAE; NONHUMAN; REVIEW; VIRUS CELL INTERACTION; VIRUS REPLICATION;

AIDS VACCINES; ANIMALS; ANTIGENIC VARIATION; DRUG DISCOVERY; EQUINE INFECTIOUS ANEMIA; GENETIC VARIATION; HORSES; HUMANS; INFECTIOUS ANEMIA VIRUS, EQUINE;

EID: 84888864919     PISSN: 19994915     EISSN: None     Source Type: Journal    
DOI: 10.3390/v5122963     Document Type: Review

References (59)

1. Lignée, M. Mémoire et observations sur une maladie de sang, connue sous le nom d'anhémie hydrohémie, cachexie acquise du cheval. Rec. Med. Vet. Ec Alfort. 1843, 20, 30-45, (In French).
2. Craigo, J.K.; Montelaro, R.C. Equine Infectious Anemia Virus (Retroviridae). In Encyclopedia of Virology, 3rd ed.; Elsevier: Oxford, UK, 2008; Volume 3, pp. 167-174.
3. Montelaro, R.C.; Ball, J.M.; Rushlow, K. Equine Retroviruses. In The Retroviridae; Levy, J.A., Ed.; Plenum Press: New York, NY, USA, 1993; Volume 2, pp. 257-360.
4. Clements, J.E.; Zink, M.C.; Narayan, O.; Gabuzda, D. Lentivirus infection of macrophages. Immunol. Ser. 1994, 60, 589-600.
5. Oaks, J.L.; McGuire, T.C.; Ulibarri, C.; Crawford, T. Equine infectious anemia virus is found in tissue macrophages during subclinical infection. J. Virol. 1998, 72, 7263-7269.
6. Harrold, S.M.; Cook, S.J.; Cook, R.F.; Rushlow, K.E.; Issel, C.J.; Montelaro, R.C. Tissue sites of persistent infection and active replication of equine infectious anemia virus during acute disease and asymptomatic infection in experimentally infected equids. J. Virol. 2000, 74, 3112-3121.
7. Hammond, S.A.; Li, F.; McKeon, B.M., Sr.; Cook, S.J.; Issel, C.J.; Montelaro, R.C. Immune responses and viral replication in long-term inapparent carrier ponies inoculated with equine infectious anemia virus. J. Virol. 2000, 74, 5968-5981.
8. Kono, Y.; hirasawa, K.; Fukunaga, Y.; Taniguchi, T. Recrudesence of equine infectious anemia by treatment with immunosuppressive drugs. Nat. Inst. Anim. Hlth. Quart. 1976, 16, 8-15.
9. Craigo, J.K.; Leroux, C.; Howe, L.; Steckbeck, J.D.; Cook, S.J.; Issel, C.J.; Montelaro, R.C. Transient immune suppression of inapparent carriers infected with a principal neutralizing domain-deficient equine infectious anaemia virus induces neutralizing antibodies and lowers steady-state virus replication. J. Gen. Virol. 2002, 83, 1353-1359.
10. Pandrea, I.; Onanga, R.; Kornfeld, C.; Rouquet, P.; Bourry, O.; Clifford, S.; Telfer, P.T.; Abernethy, K.; White, L.T.; Ngari, P.; et al. High levels of sivmnd-1 replication in chronically infected mandrillus sphinx. Virology 2003, 317, 119-127.
11. Pandrea, I.; Onanga, R.; Souquiere, S.; Mouinga-Ondeme, A.; Bourry, O.; Makuwa, M.; Rouquet, P.; Silvestri, G.; Simon, F.; Roques, P.; et al. Paucity of CD4+ CCR5+ T cells may prevent transmission of simian immunodeficiency virus in natural nonhuman primate hosts by breast-feeding. J. Virol. 2008, 82, 5501-5509.
12. VandeWoude, S.; Apetrei, C. Going wild: Lessons from naturally occurring T-lymphotropic lentiviruses. Clin. Microbiol. Rev. 2006, 19, 728-762.
13. Leroux, C.; Issel, C.; Montelaro, R.C. Novel and dynamic evolution of equine infectious anemia virus genomic quasispecies associated with sequential disease cycles in an experimentally infected pony. J. Virol. 1997, 71, 9627-9639.
14. Leroux, C.; Craigo, J.K.; Issel, C.J.; Montelaro, R.C. Equine infectious anemia virus genomic evolution in progressor and nonprogressor ponies. J. Virol. 2001, 75, 4570-4583.
15. Lichtenstein, D.L.; Issel, C.J.; Montelaro, R.C. Genomic quasispecies associated with the initiation of infection and disease in ponies experimentally infected with equine infectious anemia virus. J. Virol. 1996, 70, 3346-3354.
16. Sponseller, B.A.; Sparks, W.O.; Wannemuehler, Y.; Li, Y.; Antons, A.K.; Oaks, J.L.; Carpenter, S. Immune selection of equine infectious anemia virus env variants during the long-term inapparent stage of disease. Virology 2007, 363, 156-165.
17. Zheng, Y.H.; Nakaya, T.; Sentsui, H.; Kameoka, M.; Kishi, M.; Hagiwara, K.; Takahashi, H.; Kono, Y.; Ikuta, K. Insertions, duplications and substitutions in restricted gp90 regions of equine infectious anemia virus during febrile episodes in an experimentally infected horse. J. Gen. Virol. 1997, 78, 807-820.
18. Zheng, Y.H.; Sentsui, H.; Nakaya, T.; Kono, Y.; Ikuta, K. In vivo dynamics of equine infectious anemia viruses emerging during febrile episodes: Insertions/duplications at the principal neutralizing domain. J. Virol. 1997, 71, 5031-5039.
19. Zheng, Y.H.; Sentsui, H.; Kono, Y.; Ikuta, K. Mutations occurring during serial passage of japanese equine infectious anemia virus in primary horse macrophages. Virus Res. 2000, 68, 93-98.
20. Craigo, J.K.; Sturgeon, T.J.; Cook, S.J.; Issel, C.J.; Leroux, C.; Montelaro, R.C. Apparent elimination of EIAV ancestral species in a long-term inapparent carrier. Virology 2006, 344, 340-353.
21. Greene, W.K.; Meers, J.; del Fierro, G.; Carnegie, P.R.; Robinson, W.F. Extensive sequence variation of feline immunodeficiency virus env genes in isolates from naturally infected cats. Arch. Virol. 1993, 133, 51-62.
22. Leroux, C.; Chastang, J.; Greenland, T.; Mornex, J.F. Genomic heterogeneity of small ruminant lentiviruses: Existence of heterogeneous populations in sheep and of the same lentiviral genotypes in sheep and goats. Arch. Virol. 1997, 142, 1125-1137.
23. Simmonds, P.; Balfe, P.; Ludlam, J.; Bishop, O.; Brown, A.J. Analysis of sequence diversity in hypervariable regions of the external glycoprotein of human immunodeficiency virus type 1. J. Virol. 1990, 64, 5840-5850.
24. Starcich, E.S.; Hahn, B.H.; Shaw, G.M.; McNeely, P.D.; Modrow, S.; Wolf, H.; Parks, E.S.; Parks, W.P.; Josephs, S.F.; Gallo, R.C. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/Lav, the retrovirus of AIDS. Cell 1986, 45, 637-648.
25. Suarez, D.L.; Whetstone, C.A. Identification of hypervariable and conserved regions in the surface envelope gene in the bovine lentivirus. Virology 1995, 212, 728-733.
26. Craigo, J.K.; Barnes, S.; Cook, S.J.; Issel, C.J.; Montelaro, R.C. Divergence, not diversity of an attenuated equine lentivirus vaccine strain correlates with protection from disease. Vaccine 2010, 28, 8095-8104.
27. Blankson, J.N.; Persaud, D.; Siliciano, R.F. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 2002, 53, 557-593.
28. Chun, T.W.; Carruth, L.; Finzi, D.; Shen, X.; DiGiuseppe, J.A.; Taylor, H.; Hermankova, M.; Chadwick, K.; Margolick, J.; Quinn, T.C.; et al. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 1997, 387, 183-188.
29. Finzi, D.; Blankson, J.; Siliciano, J.D.; Margolick, J.B.; Chadwick, K.; Pierson, T.; Smith, K.; Lisziewicz, J.; Lori, F.; Flexner, C.; et al. Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 1999, 5, 512-517.
30. Persaud, D.; Zhou, Y.; Siliciano, J.M.; Siliciano, R.F. Latency in human immunodeficiency virus type 1 infection: No easy answers. J. Virol. 2003, 77, 1659.
31. Han, Y.; Lassen, K.; Monie, D.; Sedaghat, A.R.; Shimoji, S.; Liu, X.; Pierson, T.C.; Margolick, J.B.; Siliciano, R.F.; Siliciano, J.D. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 2004, 78, 6122-6133.
32. Lassen, K.G.; Bailey, J.R.; Siliciano, R.F. Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo. J. Virol. 2004, 78, 9105-9114.
33. Issel, C.J.; Adams, W.V., Jr.; Meek, L.; Ochoa, R. Transmission of equine infectious anemia virus from horses without clinical signs of disease. J. Am. Vet. Med. Assoc. 1982, 180, 272-275.
34. McGuire, T.C.; Tumas, D.B.; Byrne, K.M.; Hines, M.T.; Leib, S.R.; Brassfield, A.L.; O'Rourke, K.I.; Perryman, L.E. Major histocompatibility complex-restricted cd8+ cytotoxic T lymphocytes from horses with equine infectious anemia virus recognize env and gag/pr proteins. J. Virol. 1994, 68, 1459-1467.
35. O'Rourke, K.I.; Perryman, L.E.; McGuire, T.C. Antiviral, antiglycoprotein and neutralizing antibodies in foals with equine infectious anaemia virus. J. Gen. Virol. 1988, 69, 667-674.
36. Rwambo, P.M.; Issel, C.J.; Adams, W.V., Jr.; Hussain, K.A.; Miller, M.; Montelaro, R.C. Equine infectious anemia virus (eiav) humoral responses of recipient ponies and antigenic variation during persistent infection. Arch. Virol. 1990, 111, 199-212.
37. Montelaro, R.C.; Ball, J.M.; Issel, C.J. Characterization of eiav immunogenicity during persistent infections: Humoral responses and antigen targets. Dev. Biol Stand. 1990, 72, 19-30.
38. Hammond, S.A.; Cook, S.J.; Lichtenstein, D.L.; Issel, C.J.; Montelaro, R.C. Maturation of the cellular and humoral immune responses to persistent infection in horses by equine infectious anemia virus is a complex and lengthy process. J. Virol. 1997, 71, 3840-3852.
39. Montelaro, R.C.; Cole, K.S.; Hammond, S.A. Maturation of immune responses to lentivirus infection: Implications for AIDS vaccine development. AIDS Res. Hum. Retrovir. 1998, 14, S255-S259.
40. Hussain, K.A.; Issel, C.J.; Schnorr, K.L.; Rwambo, P.M.; West, M.; Montelaro, R.C. Antigenic mapping of the envelope proteins of equine infectious anemia virus: Identification of a neutralization domain and a conserved region on glycoprotein 90. Arch. Virol. 1988, 98, 213-224.
41. Payne, S.L.; Fang, F.D.; Liu, C.P.; Dhruva, B.R.; Rwambo, P.; Issel, C.J.; Montelaro, R.C. Antigenic variation and lentivirus persistence: Variations in envelope gene sequences during eiav infection resemble changes reported for sequential isolates of HIV. Virology 1987, 161, 321-331.
42. Payne, S.L.; Salinovich, O.; Nauman, S.M.; Issel, C.J.; Montelaro, R.C. Course and extent of variation of equine infectious anemia virus during parallel persistent infections. J. Virol. 1987, 61, 1266-1270.
43. Payne, S.L.; Rushlow, K.; Dhruva, B.R.; Issel, C.J.; Montelaro, R.C. Localization of conserved and variable antigenic domains of equine infectious anemia virus envelope glycoproteins using recombinant env-encoded protein fragments produced in escherichia coli. Virology 1989, 172, 609-615.
44. Perryman, L.E.; O'Rourke, K.I.; McGuire, T.C. Immune responses are required to terminate viremia in equine infectious anemia lentivirus infection. J. Virol. 1988, 62, 3073-3076.
45. Howe, L.; Leroux, C.; Issel, C.J.; Montelaro, R.C. Equine infectious anemia virus envelope evolution in vivo during persistent infection progressively increases resistance to in vitro serum antibody neutralization as a dominant phenotype. J. Virol. 2002, 76, 10588.
46. Howe, L.; Craigo, J.K.; Issel, C.J.; Montelaro, R.C. Specificity of serum neutralizing antibodies induced by transient immune suppression of inapparent carrier ponies infected with a neutralization-resistant equine infectious anemia virus envelope strain. J. Gen. Virol. 2005, 86, 139-149.
47. Tagmyer, T.L.; Craigo, J.K.; Cook, S.J.; Issel, C.J.; Montelaro, R.C. Envelope-specific t-helper and cytotoxic t-lymphocyte responses associated with protective immunity to equine infectious anemia virus. J. Gen. Virol. 2007, 88, 1324-1336.
48. Tagmyer, T.L.; Craigo, J.K.; Cook, S.J.; Even, D.L.; Issel, C.J.; Montelaro, R.C. Envelope determinants of equine infectious anemia virus vaccine protection and the effects of sequence variation on immune recognition. J. Virol. 2008, 82, 4052-4063.
49. Issel, C.J.; Horohov, D.W.; Lea, D.F.; Adams, W.V., Jr.; Hagius, S.D.; McManus, J.M.; Allison, A.C.; Montelaro, R.C. Efficacy of inactivated whole-virus and subunit vaccines in preventing infection and disease caused by equine infectious anemia virus. J. Virol. 1992, 66, 3398-3408.
50. Wang, S.Z.; Rushlow, K.E.; Issel, C.J.; Cook, R.F.; Cook, S.J.; Raabe, M.L.; Chong, Y.H.; Costa, L.; Montelaro, R.C. Enhancement of eiav replication and disease by immunization with a baculovirus-expressed recombinant envelope surface glycoprotein. Virology 1994, 199, 247-251.
51. Grund, C.H.; Lechman, E.R.; Pezzuolo, N.A.; Issel, C.J.; Montelaro, R.C. Fine specificity of equine infectious anaemia virus gp90-specific antibodies associated with protective and enhancing immune responses in experimentally infected and immunized ponies. J. Gen. Virol. 1996, 77, 435-442.
52. Raabe, M.L.; Issel, C.J.; Cook, S.J.; Cook, R.F.; Woodson, B.; Montelaro, R.C. Immunization with a recombinant envelope protein (rgp90) of eiav produces a spectrum of vaccine efficacy ranging from lack of clinical disease to severe enhancement. Virology 1998, 245, 151-162.
53. Shen, R.X.; Wang, Z. Development and Use of an Equine Infectious Anemia Donkey Leucocyte Attenuated Vaccine. EIAV: A National Review of Policies, Programs, and Future Objectives; American Quarter Horse Association: Amarillo, TX, USA, 1985; pp. 135-148.
54. Craigo, J.K.; Zhang, B.; Barnes, S.; Tagmyer, T.L.; Cook, S.J.; Issel, C.J.; Montelaro, R.C. Envelope variation as a primary determinant of lentiviral vaccine efficacy. Proc. Natl. Acad. Sci. USA 2007, 104, 15105-15110.
55. Cook, R.F.; Cook, S.J.; Bolin, P.S.; Howe, L.J.; Zhou, W.; Montelaro, R.C.; Issel, C.J. Genetic immunization with codon-optimized equine infectious anemia virus (EIAV) surface unit (SU) envelope protein gene sequences stimulates immune responses in ponies. Vet. Microbiol. 2005, 108, 23-37.
56. Craigo, J.K.; Durkin, S.; Sturgeon, T.J.; Tagmyer, T.; Cook, S.J.; Issel, C.J.; Montelaro, R.C. Immune suppression of challenged vaccinates as a rigorous assessment of sterile protection by lentiviral vaccines. Vaccine 2007, 25, 834-845.
57. Hammond, S.A.; Cook, S.J.; Falo, L.D., Jr.; Issel, C.J.; Montelaro, R.C. A particulate viral protein vaccine reduces viral load and delays progression to disease in immunized ponies challenged with equine infectious anemia virus. Virology 1999, 254, 37-49.
58. Li, F.; Craigo, J.K.; Howe, L.; Steckbeck, J.D.; Cook, S.; Issel, C.; Montelaro, R.C. A live attenuated equine infectious anemia virus proviral vaccine with a modified S2 gene provides protection from detectable infection by intravenous virulent virus challenge of experimentally inoculated horses. J. Virol. 2003, 77, 7244-7253.
59. Craigo, J.K.; Li, F.; Steckbeck, J.D.; Durkin, S.; Howe, L.; Cook, S.J.; Issel, C.; Montelaro, R.C. Discerning an effective balance between equine infectious anemia virus attenuation and vaccine efficacy. J. Virol. 2005, 79, 2666-2677.